Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOURISH-MASH
NCT07680478Phase 4Not yet recruiting
- Sponsor
- City University of New York
- Start
- Oct 2026
- Primary completion
- Feb 2028
- Countries
- 1
01
Overview
A Phase 4 trial of resmetirom in metabolic dysfunction-associated steatohepatitis (MASH), sponsored by City University of New York. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
resmetirom
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on NCT07680478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07680478.